Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

ACSG

American Century Small Cap Growth Insights ETF (ACSG)

Rating:64Neutral
Price Target:$49.00â–²(6.36% Upside)

ACSG, the American Century Small Cap Growth Insights ETF, appears to offer solid but not outstanding quality, driven by several strong growth-focused holdings like Krystal Biotech, which benefits from successful international expansion and robust earnings, and Hexcel, which adds stability through strong cash flow management and bullish momentum. However, some holdings such as Radnet and Sensient Technologies face profitability, cash flow, and bearish technical challenges, which likely weigh on the fund’s overall rating. A key risk factor is that many top positions show signs of high valuation or overbought conditions, meaning investors should be mindful of potential volatility and downside if growth expectations are not met.

Positive Factors
Strong Top HoldingsMany of the largest positions have shown strong gains this year, which has helped support the ETF’s overall results.
Broad Sector DiversificationThe fund spreads its investments across many sectors, with meaningful exposure to health care, technology, industrials, and others, helping reduce reliance on any single industry.
Focused Small-Cap Growth ExposureThe ETF offers targeted access to small, fast-growing companies, which can provide higher growth potential over time compared with larger, more mature firms.
Negative Factors
Recent Short-Term WeaknessThe ETF has experienced weak performance over the last one and three months, which may signal near-term volatility or pressure on small-cap growth stocks.
High U.S. ConcentrationWith almost all assets invested in U.S. companies, the fund offers very little geographic diversification and is heavily tied to the U.S. market.
Moderate Expense RatioThe fund’s fee is not especially low for an ETF, which can slightly reduce net returns over the long term compared with cheaper alternatives.

ACSG vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%SPY+13.89%ACSG+18.70%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
53.97M
Region
North America
Expense Ratio
0.49%
Beta
1.20
Issuer
American Century
Inception Date
Oct 14, 2025
Dividend Yield
5.33%
Asset Class
Equity
Index Tracked
No Underlying Index

ACSG Summary

American Century Small Cap Growth Insights ETF (ACSG) is an actively managed fund that focuses on smaller U.S. companies that the managers believe have strong growth potential. It doesn’t track a set index, but instead picks individual stocks, with a lot of exposure to health care, technology, and industrial businesses. Examples of companies it holds include Krystal Biotech and Hexcel. Someone might invest in ACSG to seek long-term growth and to diversify beyond large, well-known stocks. A key risk is that small-company shares can be more volatile and can go up and down more sharply than the overall market.

How much will it cost me?

This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 you invest. That’s higher than the average index (passive) ETF because this fund is actively managed, with managers researching and selecting small-cap growth stocks for you.

What would affect this ETF?

This ETF could benefit if the U.S. economy stays healthy, investors favor fast-growing small companies, and innovation in areas like health care and technology continues to attract money to its key sectors and top biotech and software holdings. On the other hand, it could be hurt by higher interest rates, an economic slowdown that hits small businesses harder than large ones, or regulatory and reimbursement changes that weigh on health care and biotech stocks in particular.

ACSG Top 10 Holdings

ACSG is leaning heavily into U.S. small-cap health care and tech, with names like 10x Genomics and Krystal Biotech acting as the fund’s high-octane growth engines—though their ride has been bumpy, with strong longer-term momentum but some recent lagging. Sensient Technologies has been a steady bright spot, rising and helping to anchor returns, while Agilysys adds a more mixed but still growth-oriented tech flavor. On the flip side, CECO Environmental has been losing steam, weighing on performance. Overall, this is a U.S.-focused, innovation-driven portfolio with a clear tilt toward small, fast-growing medical and technology players.

ACSG top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
AGYSAGYSAgilysys0.87%$471.95K$3.48B-5.39%73Outperform
MGNIMGNIMagnite0.88%$473.00K$4.19B106.47%68Neutral
WFRDWFRDWeatherford International0.86%$464.75K$6.28B17.88%72Outperform
RDNTRDNTRadnet0.83%$446.85K$6.15B2.14%63Neutral
KRYSKRYSKrystal Biotech0.81%$437.27K$9.15B50.56%80Outperform
LTHLTHLife Time Group Holdings0.80%$434.00K$10.67B75.69%71Outperform
HXLHXLHexcel0.77%$415.31K$6.17B16.27%73Outperform
HRIHRIHerc Holdings0.81%$434.58K$5.82B19.39%67Neutral
EHCEHCEncompass Health0.76%$410.36K$13.96B22.67%64Neutral
SXTSXTSensient Technologies0.73%$392.67K$5.06B22.33%63Neutral

ACSG Technical Analysis

Technical Analysis SentimentPositive
Last Price46.07

Price Trends

50DMA46.24Negative
100DMA47.72Negative
200DMA45.62Positive

Market Momentum

MACD0.00Negative
RSI50.52Neutral
STOCH78.49Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACSG, the sentiment is Positive. The current price of 46.07 is above the 20-day moving average (MA) of 45.65, below the 50-day MA of 46.24, and above the 200-day MA of 45.62, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 50.52 is Neutral, neither overbought nor oversold. The STOCH value of 78.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACSG.

ACSG Peer Comparison

Comparison Results

ACSG against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
ACSGACSG$46.07$49.00(6.36% Upside)$53.97M0.49%64Neutral
TMFSTMFS$34.43$43.46(26.25% Upside)$52.83M0.85%63Neutral
MMSCMMSC$26.34$33.64(27.73% Upside)$52.26M0.95%63Neutral
SGRWSGRW$24.81$35.00(41.05% Upside)$28.54M0.80%60Neutral
FSEGFSEG$25.92$35.99(38.88% Upside)$7.80M0.28%62Neutral
SAWSSAWS$22.12$26.50(19.85% Upside)$6.87M0.55%68Neutral

Performance Comparison

-10%0%10%20%30%ACSGTMFSMMSCSGRWFSEGSAWSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ACSG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ACSGAmerican Century Small Cap Growth Insights ETF46.076.6016.73%
TMFSMotley Fool Small-Cap Growth ETF34.430.922.74%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF26.343.4014.82%
SGRWHarbor Active Small Cap Growth ETF24.814.5222.28%
FSEGFidelity Enhanced Small Cap Growth ETF25.910.692.72%
SAWSAAM Sawgrass US Small Cap Quality Growth ETF22.111.617.86%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.